IndiaMART InterMESH News and Updates

Name: Latest research reports of IndiaMART InterMESH Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: IndiaMART InterMESH Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news on IndiaMART InterMESH from all sources in a single place.

IndiaMART InterMESH Ltd.

21 Apr 2026, 09:20AM

2186.00

0.88%

Fake Mounjaro injection manufacturing racket busted in Gurugram; 2 arrested

Business Standard

Authorities have unearthed a racket involving the manufacturing and sale of "fake" Mounjaro (tirzepatide) injections and arrested two persons here in this connection, an official said on Monday. A nationwide alert has been issued to detect the counterfeit injections and an investigation is underway to unravel the entire network, including all those involved in this racket, Drug Control Officer Amandeep Chauhan said. He said a Health Department team raided a residential society in Sector 62 on Monday and arrested two people, including the key accused. The accused were importing raw drugs from China and manufacturing counterfeit injections of Mounjaro. The entire racket was being run from a flat in the society. The accused supplied these illegal injections through the B2B portal Indiamart, the officer alleged. Mounjarois a weekly injectable medication for type 2 diabetesthat significantly improves blood sugar control and aids weight loss. "We received information about a fake inject

IndiaMART InterMESH Ltd. is trading above its 100 day SMA of 2181.4

IndiaMART InterMESH Ltd.

20 Jan 2026, 03:58PM

2186.00

0.88%

to see Rapid results content

IndiaMART InterMESH Ltd.

20 Jan 2026

2186.00

0.88%

Holding the course

Buy: IndiaMART InterMESH Ltd.

Target

Motilal Oswal

IndiaMART (INMART) reported 3QFY26 revenue growth of 13% YoY vs. our estimate of 11% YoY growth. Deferred revenue rose 17% YoY to INR17.5b. EBITDA margin expanded ~30bp QoQ to 33.5%, above our estimate of 31.1%.

Number of FII/FPI investors decreased from 262 to 244 in Mar 2026 qtr

IndiaMART InterMESH Ltd.

17 Dec 2025

2186.00

0.88%

Indiamart Gets HDFC Securities 'Buy' Upgrade With Revised Target Price Here's Why

NDTV Profit

HDFC Securities upgrades IndiaMart shares to 'Buy' from 'Add' implying an upside of 24%.

IndiaMART InterMESH Ltd. is trading above its 100 day SMA of 2181.4

IndiaMART InterMESH Ltd.

28 Oct 2025

2186.00

0.88%

IndiaMart Eyes Double-Digit Growth In Standalone Collections In H2FY26

NDTV Profit

IndiaMart is heavily investing in AI to enhance operational efficiency and customer experience.

IndiaMART InterMESH .. has an average target of 2789.25 from 4 brokers.

IndiaMART InterMESH Ltd.

23 Oct 2025

2186.00

0.88%

3 reasons why Axis Securities slashed IndiaMART Intermesh target price

Business Standard

IndiaMART Intermesh outlook: Analysts remain optimistic about the broader digital B2B marketplace opportunity and believes IndiaMART is well-placed to sustain growth as MSME digitisation deepens.

IndiaMART InterMESH Ltd.'s price crossed below 100Day SMA today

IndiaMART InterMESH Ltd.

20 Oct 2025

2186.00

0.88%

Result Update:Indiamart Inter.

Hold: IndiaMART InterMESH Ltd.

Target

Axis Direct

We recommend HOLD a rating on the stock

Number of FII/FPI investors decreased from 262 to 244 in Mar 2026 qtr

IndiaMART InterMESH Ltd.

17 Oct 2025

2186.00

0.88%

to see Rapid results content

IndiaMART InterMESH Ltd.

17 Oct 2025

2186.00

0.88%

Battling in familiar waters

Buy: IndiaMART InterMESH Ltd.

Target

Motilal Oswal

IndiaMART (INMART) reported 2QFY26 revenue growth of 12% YoY vs. our estimate of 9.5% YoY growth. Deferred revenue rose 17% YoY to INR17.5b.

IndiaMART InterMESH .. has an average target of 2789.25 from 4 brokers.

IndiaMART InterMESH Ltd.

21 Jul 2025, 03:01PM

2186.00

0.88%

'Buy' IndiaMart Shares Maintains Motilal Oswal Post Q1 Results, Citing Undemanding Valuations

NDTV Profit

Currently, IndiaMart is trading at an undemanding valuation, in the brokerage's view, as the valuations reflect uncertainties surrounding the churn rate, productmarket fit, and subscriber growth.